The medication for the treatment of liver diseases and biliary tract

Consumers survey results of 2012 in category

Digestive system and hepatology / The medication for the treatment of liver diseases and biliary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Essentiale Forte N (Sanofi)	40.00%	5

2.	5	Карсил (Sopharma)	24.00%	2.87

3.		Галстена (Perrigo)	20.00%	2.50

4.	1	Hepabene (ratiopharm)	22.00%	2.33

5.	4	Алохол (Борщагівський ХФЗ)	14.00%	1.72

–.	7	~~Enterosgelum (Kreoma-Pharm)~~	~~14.00%~~	~~1.66~~

6.	8	Лів.52 (Фірма ТК Комфорт)	8.00%	1.09

7.	16	Antralum (Farmak)	8.00%	1.03

–.	6	~~Уролесан (Arterium Corporation)~~	~~10.00%~~	1

8.	11	Енерлів (Berlin-Chemie Menarini)	8.00%	0.95

9.	12	Дарсіл (Darnitsa)	6.00%	0.91

10.		Chophytol (Lab. Rosa-Phytopharma)	8.00%	0.89

11.	~	Легалон (Madaus)	6.00%	0.84

–.	24	~~Ессел Форте (Nabros Pharma)~~	~~6.00%~~	~~0.70~~

12.	25	Гепатофіт (Aim)	6.00%	0.63

12.	28	Силімарин Гексал (Sandoz)	6.00%	0.63

14.	26	Холензим (Біосинтез)	4.00%	0.58

–.	9	~~Дуфалак (Abbott Laboratories)~~	~~4.00%~~	~~0.52~~

15.	18	Холівер (Hau Giang Ph. JSK-HG Pharm)	4.00%	0.52

–.	21	~~Беластезин (Борщагівський ХФЗ)~~	~~4.00%~~	~~0.44~~

16.	19	Гепалекс (Sandoz)	4.00%	0.44

–.	14	~~Гербіон (KRKA)~~	~~4.00%~~	~~0.44~~

16.	15	Цитраргінін (Zambon France)	4.00%	0.44

18.	13	Артишока екстракт Гексал (Sandoz)	2.00%	0.26

18.	27	Холензим (Belmedpreparaty)	2.00%	0.26

20.	18	Нукс Воміка (Heel)	2.00%	0.19

20.	33	Фосфоліп (Universal Medicare)	2.00%	0.19

20.	17	Холагол (Teva)	2.00%	0.19

–.		Febichol (Noventis)	0.00%	0

–.		Raphacholin C (Herbapol)	0.00%	0

–.	34	Артіхол (Київський вітамінний завод)	0.00%	0

–.	22	Берези бруньки (Ternopharm)	0.00%	0

–.	33	Биликур (Sandoz)	0.00%	0

–.	32	Бонджигар (Herbion)	0.00%	0

–.	34	Бренціале Форте (Бринцалов-А)	0.00%	0

–.	31	Гепа-Мерц (Merz Pharmaceuticals)	0.00%	0

–.	34	Гепарсил (Стиролбіофарм)	0.00%	0

–.		Гепато-флора (Медіфлора)	0.00%	0

–.	30	Гепафорте (Bosnalijek)	0.00%	0

–.		Глутаргін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.	23	Есслівер Форте (Stada)	0.00%	0

–.	32	Левасіл (Micro Labs)	0.00%	0

–.	29	Ліволін Форте (Mega Lifesciences)	0.00%	0

–.		ПМ Сірін (N. Kapharma Pharmaceuticals)	0.00%	0

–.	34	Силібор (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Силімарол (Євролек)	0.00%	0

–.		Симепар (Teva)	0.00%	0

–.	20	Фламін (Arterium Corporation)	0.00%	0

–.	30	Холе-гран (Національна гомеопатична спілка)	0.00%	0

–.	33	Цінарікс (Montavit)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2012, recommendation of consumers #1 in the category “The drug for the treatment of liver diseases and biliary tract”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2012, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.